ZYMVOL is start-up specialized in computer-driven biocatalyst discovery and development for the pharmaceutical and fine chemical industry. We harness the power of high-performance computing to identify and optimize custom-made biocatalysts that deliver additional value. The major problem being addressed by the UNLOCK-EDD project is improvement of computational methodologies, capable of addressing enzyme discovery and design campaigns in a time and cost-efficient manner. Furthermore, we are also introducing new custom-made enzymes that solve specific industrial problems.
Biocatalysts are enzymes that accelerate industrial chemical reactions and have multiple applications for the synthesis of chemical compounds. The main benefits of the use of enzymes with respect to standard catalysis are related with their ability to work at low temperatures, atmospheric pressure and deliver high purity products with a minimal use of water and resources. These factors have a huge impact on the environment and in the future, most products should be obtained through biocatalysis. Furthermore, due to the highly technical profile of our employees we are addressing and important problem of our society: maintaining the talent in the South of Spain. Our company impacts not only the production of goods but also is a pillar in the bioeconomy.
The overall objectives of the project are:
Technical: 1) Improve predictability and production capacity through the integration of artificial intelligence algorithms; 2) Develop software module for the discovery and design of special purpose-enzyme kits (ZYME-Kit) and their testing in appropriate industrial environment.
Commercial: 1) Software Upgrading & Automation – Deployment into ZYMEVOLVER; 2) Regulatory compliance. 3) Perform dissemination and communication actions; 4) International growth.
